Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Multi-modal virtual reminiscence therapy with an AI avatar for older adults with Alzheimer's and related dementias

Official title: Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD

Run by Indiana University · NCT07499570 · Data updated 2026-11-12

This study will test whether a smart virtual reminiscence program with an interactive avatar can reduce behavioral and psychological symptoms in older adults with mild Alzheimer's or related dementias.

More Mild Cognitive Impairment trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment60 (estimated)
SponsorIndiana University
Academic / other
Locations1 site (Indianapolis, Indiana)
StatusRecruiting
StartedSeptember 3, 2025
Main results expectedMarch 1, 2027
Study endsMarch 1, 2027
Registry record updatedMay 6, 2026
Trial IDNCT07499570 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling adults aged 65 or older with mild cognitive impairment or mild Alzheimer's-related dementia, elevated BPSD (HABC score >14), reliable internet access, the ability to consent, and a willing care partner.

Probably not a fit

Patients in assisted living or nursing homes, those with moderate to severe dementia, or with life expectancy under six months are unlikely to benefit or be eligible for this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patient–caregiver dyads are randomized to receive Smart Virtual Reminiscence (SVR) therapy delivered by a multi-modal avatar or an attention control of listening to music. SVR is a computer-accessible program that uses large language model–driven speech understanding, avatar nonverbal cues, and automatically assembled personal reminiscence materials (photos, music, videos) so a human facilitator is not required. Sessions can be completed at the study site or at home via a reliable internet connection with caregiver support as needed. The study measures changes in behavioral and psychological symptoms of dementia using caregiver- and self-report instruments.

Why it matters

Potential benefit: If successful, SVR could provide a scalable, at-home non-drug therapy that lessens agitation, anxiety, and other behavioral symptoms and improves patient well-being.

How similar studies have gone: Reminiscence therapy and other nonpharmacological approaches have shown benefits for mood and behavioral symptoms, but fully automated LLM-driven avatar delivery is novel and has limited prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
For the patient:

Inclusion criteria:

* age ≥ 65 years
* diagnosis of MCI (mild cognitive impairment) or mild ADRD
* access to a reliable internet connection
* community-dwelling
* elevated behavioral and psychological symptoms of dementia (BPSD), indicated by a HABC (Healthy Aging Brain Care) monitor score above 14 on caregiver report or self report (indicating elevated levels of BPSD)
* presence of one or more specific BPSD behaviors (e.g., agitation, anxiety, depression, apathy, or sleep disturbances)
* ability to consent for themselves.

Exclusion criteria:

* lives in an assisted living facility or nursing home
* has moderate to severe ADRD as measured by the Quick Dementia Rating System
* has a life expectancy of less than 6 months.

For the care partner:

Inclusion criteria:

* ≥ 21 years old
* self-identified care partner (e.g., is knowledgeable about the patient's daytime and nighttime behaviors) of a community-dwelling patient diagnosed with MCI or mild ADRD who will also participate in the study

Exclusion criteria:

* has MCI or dementia
* has a severe mental illness or substance abuse
* has a life expectancy of less than 6 months.

Where it's running

  • Sidney & Lois Eskenazi Hospital
    Indianapolis, Indiana, United States
    Recruiting

Study contacts

  • Principal investigator: Malaz Boustani, MD, MPH — Indiana University
  • Study coordinator: Katrina Coppedge, BA
  • Email: kcoppedg@iu.edu
  • Phone: 317-278-1602

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.